Revance Therapeutics Inc (RVNC.O)

+ 收藏

资产负债表(Revance Therapeutics Inc)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
截止日期 2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-31
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 1231123112311231123112311231
原始币种 美元美元美元美元美元美元美元
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 会员可见会员可见会员可见会员可见179,319,000.00141,235,000.00136,678,000.00
 受限制存款及现金流动(元) 会员可见会员可见会员可见会员可见275,000.00275,000.00275,000.00
 应收账款及票据(元) 会员可见会员可见会员可见会员可见25,414,000.0017,043,000.0015,373,000.00
 预付款项及其他应收款流动(元) 会员可见会员可见会员可见会员可见16,371,000.007,458,000.005,652,000.00
 存货(元) 会员可见会员可见会员可见会员可见46,214,000.0034,448,000.0027,775,000.00
 短期投资(元) 会员可见会员可见会员可见会员可见120,926,000.00178,488,000.00137,271,000.00
 流动资产其他项目(元) 会员可见会员可见会员可见----
 流动资产合计(元) 会员可见会员可见会员可见会员可见388,519,000.00378,947,000.00323,024,000.00
非流动资产:
 物业、厂房及设备(元) 会员可见会员可见会员可见会员可见17,179,000.0012,690,000.0013,953,000.00
 受限制存款及现金非流动(元) 会员可见会员可见会员可见会员可见7,145,000.007,145,000.007,145,000.00
 无形资产(元) 会员可见会员可见会员可见会员可见10,507,000.0028,461,000.0031,223,000.00
 商誉(元) -----77,175,000.0077,175,000.00
 预付款项及其他长期应收款非流动(元) 会员可见会员可见会员可见会员可见30,883,000.0027,500,000.0027,500,000.00
 非流动资产其他项目(元) 会员可见会员可见会员可见会员可见78,254,000.0065,617,000.0067,781,000.00
 非流动资产合计(元) 会员可见会员可见会员可见会员可见143,968,000.00218,588,000.00224,777,000.00
总资产(元) 会员可见会员可见会员可见会员可见532,487,000.00597,535,000.00547,801,000.00
流动负债:
 短期债务及长期负债本期部分(元) 会员可见会员可见会员可见会员可见1,250,000.00--
 融资租赁负债流动(元) 会员可见会员可见会员可见会员可见17,269,000.0020,766,000.0023,088,000.00
 应付账款及票据(元) 会员可见会员可见会员可见会员可见4,775,000.008,345,000.0012,996,000.00
 其他应付款及应计费用(元) 会员可见会员可见会员可见会员可见53,493,000.0039,535,000.0035,865,000.00
 递延收入流动(元) 会员可见会员可见会员可见会员可见5,371,000.005,433,000.006,036,000.00
 流动负债其他项目(元) -会员可见会员可见----
 流动负债合计(元) 会员可见会员可见会员可见会员可见82,158,000.0074,079,000.0077,985,000.00
非流动负债:
 长期债务(元) 会员可见会员可见会员可见会员可见427,101,000.00380,348,000.00379,859,000.00
 融资租赁负债非流动(元) 会员可见会员可见会员可见会员可见42,279,000.0031,274,000.0032,771,000.00
 递延收入非流动(元) 会员可见会员可见会员可见会员可见84,315,000.0082,213,000.0081,024,000.00
 非流动负债其他项目(元) 会员可见会员可见会员可见会员可见2,835,000.002,835,000.002,835,000.00
 非流动负债合计(元) 会员可见会员可见会员可见会员可见556,530,000.00496,670,000.00496,489,000.00
总负债(元) 会员可见会员可见会员可见会员可见638,688,000.00570,749,000.00574,474,000.00
股东权益:
 普通股(元) 会员可见会员可见会员可见会员可见88,000.0088,000.0084,000.00
 股本溢价(元) 会员可见会员可见会员可见会员可见1,916,385,000.001,908,244,000.001,787,535,000.00
 留存收益(元) 会员可见会员可见会员可见会员可见-2,022,661,000.00-1,881,485,000.00-1,814,167,000.00
 累计其他全面收益(元) 会员可见会员可见会员可见会员可见-13,000.00-61,000.00-125,000.00
 归属于母公司股东权益(元) 会员可见会员可见会员可见会员可见-106,201,000.0026,786,000.00-26,673,000.00
 股东权益合计(元) 会员可见会员可见会员可见会员可见-106,201,000.0026,786,000.00-26,673,000.00
负债及股东权益合计(元) 会员可见会员可见会员可见会员可见532,487,000.00597,535,000.00547,801,000.00
公告日期 2024-11-072024-08-082024-05-092024-02-282023-11-082023-08-082023-05-09
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院